Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1966 1
1989 1
1999 2
2003 8
2004 3
2005 3
2006 7
2007 5
2008 8
2009 12
2010 12
2011 14
2012 14
2013 14
2014 17
2015 24
2016 21
2017 15
2018 19
2019 19
2020 17
2021 17
2022 11
2023 11
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 26683263

247 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study.
Takatsuki M, Tokunaga S, Uchida S, Sakoda M, Shirabe K, Beppu T, Emi Y, Oki E, Ueno S, Eguchi S, Akagi Y, Ogata Y, Baba H, Natsugoe S, Maehara Y; Kyushu Study Group of Clinical Cancer (KSCC). Takatsuki M, et al. Eur J Surg Oncol. 2016 Feb;42(2):184-9. doi: 10.1016/j.ejso.2015.11.007. Epub 2015 Nov 22. Eur J Surg Oncol. 2016. PMID: 26683263 Free article. Clinical Trial.
Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).
Huiskens J, van Gulik TM, van Lienden KP, Engelbrecht MR, Meijer GA, van Grieken NC, Schriek J, Keijser A, Mol L, Molenaar IQ, Verhoef C, de Jong KP, Dejong KH, Kazemier G, Ruers TM, de Wilt JH, van Tinteren H, Punt CJ. Huiskens J, et al. BMC Cancer. 2015 May 6;15:365. doi: 10.1186/s12885-015-1323-9. BMC Cancer. 2015. PMID: 25943574 Free PMC article. Clinical Trial.
mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival.
Yasuno M, Uetake H, Ishiguro M, Mizunuma N, Komori T, Miyata G, Shiomi A, Kagimura T, Sugihara K. Yasuno M, et al. Int J Clin Oncol. 2019 May;24(5):516-525. doi: 10.1007/s10147-018-01393-8. Epub 2019 Jan 5. Int J Clin Oncol. 2019. PMID: 30612267 Free PMC article. Clinical Trial.
Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study.
Takahashi T, Shibata Y, Tojima Y, Tsuboi K, Sakamoto E, Kunieda K, Matsuoka H, Suzumura K, Sato M, Naganuma T, Sakamoto J, Morita S, Kondo K. Takahashi T, et al. Int J Clin Oncol. 2013 Apr;18(2):335-42. doi: 10.1007/s10147-012-0382-z. Epub 2012 Mar 2. Int J Clin Oncol. 2013. PMID: 22383023 Clinical Trial.
A multicenter phase II trial of mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808).
Uetake H, Yasuno M, Ishiguro M, Kameoka S, Shimada Y, Takahashi K, Watanabe T, Muro K, Baba H, Yamamoto J, Mizunuma N, Tamagawa H, Mochizuki I, Kinugasa Y, Kikuchi T, Sugihara K. Uetake H, et al. Ann Surg Oncol. 2015 Mar;22(3):908-15. doi: 10.1245/s10434-014-4094-7. Epub 2014 Dec 3. Ann Surg Oncol. 2015. PMID: 25465375 Clinical Trial.
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.
Alberts SR, Horvath WL, Sternfeld WC, Goldberg RM, Mahoney MR, Dakhil SR, Levitt R, Rowland K, Nair S, Sargent DJ, Donohue JH. Alberts SR, et al. J Clin Oncol. 2005 Dec 20;23(36):9243-9. doi: 10.1200/JCO.2005.07.740. Epub 2005 Oct 17. J Clin Oncol. 2005. PMID: 16230673 Clinical Trial.
Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S, Stift J, Singh J, Starlinger P, Gruenberger B, Tamandl D, Gruenberger T. Stremitzer S, et al. Eur J Surg Oncol. 2015 Jul;41(7):868-74. doi: 10.1016/j.ejso.2015.03.223. Epub 2015 Mar 24. Eur J Surg Oncol. 2015. PMID: 25865557 Clinical Trial.
247 results